RTX Closes In on $204 as the Post-Earnings Rally Extends

RTX Corporation has added another leg to its post-earnings recovery, with the stock up nearly 5% on the week to $203.82 and now 10% higher than a month ago, closing the gap toward a Street consensus that has itself been moving.

The gap between price and analyst target has narrowed materially since last week's note, when RTX was sitting just above $194 against a consensus mean of around $229. The stock has since closed roughly $24 of that distance. The mean target now stands at $227.91, implying around 12% upside from current levels, down from the 18% implied a week ago. The post-earnings direction of travel on targets has been bullish: Barclays raised its Overweight target to $235 from $223 within two weeks of the Q3 print, and UBS nudged to $212 from $209 while staying Neutral. Those followed earlier trims from RBC, Bernstein, and TD Cowen before the results. The broader analyst picture ranks in the 92nd percentile on consensus-recommendation differential, one of the more differentiated scores in the sector. Barclays, the most recent mover, is pointing firmly higher. UBS is not. That divergence, bulls focused on a $289 billion backlog growing 22% year on year and Raytheon's 18% organic expansion versus bears flagging supply-chain bottlenecks and GTF execution risk at Pratt and Whitney, remains the central debate.

Options positioning has drifted more cautious as the stock has rallied. The put/call ratio is at 0.93, running above its 20-day average of 0.895 and roughly 1.3 standard deviations above that mean. The ratio has climbed consistently from around 0.75 in late September, suggesting investors have added hedges as the price has pushed higher into the year's strong levels. At the same time, short interest is not telling an aggressive story at all. Shorts fell 7.3% over the week to around 1.1% of the free float, a genuinely low reading. Borrow cost is 0.32% and availability is effectively unlimited, with over a billion shares available to lend against roughly 14 million borrowed. There is no squeeze pressure here, and no sign of coordinated short-side conviction.

Valuation has re-rated with the move. The price/earnings multiple has expanded by roughly 1.6 points over 30 days to 25.5x. EV/EBITDA has ticked down slightly over the same period to 17.1x, suggesting the earnings base is growing faster than the enterprise value. The EPS surprise factor score of 70 reflects a solid but not exceptional track record of beating estimates. The earnings yield ranks near the median at the 49th percentile, consistent with a stock that is no longer cheap but not dramatically stretched relative to its own history. The next earnings date is pencilled in for January 19, leaving a 76-day window before the story is tested again by reported numbers.

One data point worth noting from the ORTEX Alt Data layer: retail attention, measured by the average of English Wikipedia page views and ORTEX page traffic on a log scale against a 90-day baseline, registered a z-score of 2.6 as of October 21. That places RTX in the upper tail of its own attention distribution. The dataset is classed as an attention indicator rather than a revenue signal, so it carries no direct read-through to fundamentals, but elevated retail attention during a price rally is a known feature of momentum phases.

Among correlated peers, LHX added 7% on the week and HII surged 12.7%, outpacing RTX's 4.7% gain. NOC was the laggard, essentially flat. The divergence suggests the week's strength was broad across defence but most concentrated in names with more compressed valuations or specific contract catalysts. RTX's move was real but middle-of-the-pack in its own peer group.

With the consensus target now closer and the next print 76 days away, the question shifts from whether Q3 was good enough to whether the current multiple leaves room for further re-rating before January's numbers arrive.